Description: Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Home Page: www.haleon.com
The Heights
Weybridge,
KT13 0NY
United Kingdom
Phone:
44 1932 822000
Officers
| Name | Title |
|---|---|
| Mr. Brian James McNamara | CEO & Executive Director |
| Mr. Tobias Hannes Hestler | Executive Officer |
| Ms. Dawn Amanda Allen | CFO & Director |
| Ms. Claire Dickson | Chief Digital & Technology Officer |
| Ms. Sonya Ghobrial | Head of Investor Relations |
| Mr. Adrian Charles Morris | General Counsel |
| Ms. Tamara Rogers | Chief Marketing Officer |
| Ms. Line De Decker | Chief Human Resources Officer |
| Mr. Filippo Lanzi | President of EMEA & LatAm |
| Mr. Keith Choy | President of Asia Pacific |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 20.3252 |
|---|---|
| Trailing PE: | 28.0882 |
| Price-to-Book MRQ: | 2.0377 |
| Price-to-Sales TTM: | 3.8416 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 25408 |